🇬🇧 UK Medical Licensing Assessment (UKMLA) · subject

UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health Syllabus

The Reproductive, Sexual and Women's Health syllabus for UK Medical Licensing Assessment (UKMLA) in full: 5 chapters, 22 topics and 44 sub-topics, every one listed below, plus 61 Reproductive, Sexual and Women's Health flashcards with answers.

5Chapters
22Topics
44Sub-topics
61Flashcards

Reproductive, Sexual and Women's Health syllabus: all 5 chapters

Expand any chapter to see its topics and sub-topics.

  1. Obstetrics: Antenatal and Intrapartum Care

    5 topics
    • Normal pregnancy and antenatal care
      • Antenatal screening and booking
      • Physiological changes in pregnancy
      • Fetal growth monitoring
    • Medical disorders in pregnancy
      • Hypertensive disorders and pre-eclampsia
      • Gestational diabetes
      • Venous thromboembolism in pregnancy
    • Antenatal complications
      • Antepartum haemorrhage (placenta praevia and abruption)
      • Preterm labour and rupture of membranes
      • Rhesus disease and isoimmunisation
    • Labour and delivery
      • Stages of labour and monitoring
      • Failure to progress and instrumental delivery
      • Caesarean section indications
    • Obstetric emergencies
      • Postpartum haemorrhage
      • Shoulder dystocia and cord prolapse
      • Eclampsia and amniotic fluid embolism
  2. Obstetrics: Early Pregnancy and Postnatal Care

    4 topics
    • Early pregnancy complications
      • Miscarriage
      • Ectopic pregnancy
      • Gestational trophoblastic disease
      • Hyperemesis gravidarum
    • Postnatal care and complications
      • Postnatal infection and sepsis
      • Perinatal mental health
    • Termination of pregnancy
    • Maternal and perinatal mortality
  3. Gynaecology

    5 topics
    • Menstrual disorders
      • Heavy menstrual bleeding
      • Amenorrhoea and oligomenorrhoea
      • Dysmenorrhoea and premenstrual syndrome
    • Benign gynaecological conditions
      • Fibroids
      • Endometriosis and adenomyosis
      • Polycystic ovary syndrome
      • Ovarian cysts
    • Pelvic pain and infection
      • Pelvic inflammatory disease
      • Chronic pelvic pain
    • Urogynaecology
      • Urinary incontinence
      • Pelvic organ prolapse
    • Menopause and its management
  4. Gynaecological Oncology

    4 topics
    • Cervical disease and screening
      • Cervical screening programme and HPV
      • Cervical cancer
    • Endometrial and uterine cancer
    • Ovarian cancer
    • Vulval and vaginal disease
  5. Contraception, Sexual and Reproductive Health

    4 topics
    • Contraception
      • Hormonal contraception
      • Long-acting reversible contraception
      • Emergency contraception
      • UK Medical Eligibility Criteria
    • Sexually transmitted infections
      • Chlamydia and gonorrhoea
      • Syphilis
      • Genital herpes and warts
      • Partner notification
    • Subfertility
      • Investigation of the infertile couple
      • Assisted reproduction principles
    • Sexual health consultation and risk assessment

UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health flashcards — 61 questions with answers

  1. During routine antenatal care in the UK, at what gestations are the two standard ultrasound scans offered?

    The dating/booking scan at $11^{+2}$ to $14^{+1}$ weeks (also used for combined Down's screening), and the anomaly (fetal anatomy) scan at $18^{+0}$ to $20^{+6}$ weeks.

  2. What is the recommended daily dose of folic acid before conception and in the first trimester, and the higher dose for high-risk women?

    $400\ \mu g$ daily for low-risk women until 12 weeks; $5\ mg$ daily for high-risk women (e.g. previous neural tube defect, diabetes, BMI $\geq 30$, antiepileptic drugs, sickle cell disease).

  3. What is the combined test for Down's syndrome screening, what does it measure, and when is it performed?

    Performed at 11–14 weeks: nuchal translucency on ultrasound plus serum $\beta$-hCG (raised) and PAPP-A (low). A risk $\geq 1\text{ in }150$ is screen-positive and prompts offer of diagnostic testing.

  4. What are the diagnostic tests for fetal chromosomal/genetic abnormalities, and at what gestations are they done?

    Chorionic villus sampling (CVS) from 11 weeks and amniocentesis from 15 weeks. CVS carries a slightly higher miscarriage risk (~$1\text{–}2\%$) than amniocentesis (~$0.5\text{–}1\%$).

  5. Define pre-eclampsia and state its diagnostic blood pressure and proteinuria thresholds.

    New-onset hypertension ($\geq 140/90\ \text{mmHg}$) after 20 weeks plus proteinuria (urine protein:creatinine ratio $\geq 30\ \text{mg/mmol}$) and/or maternal organ dysfunction. Severe: BP $\geq 160/110\ \text{mmHg}$.

  6. Which drug is given for seizure prophylaxis and treatment in severe pre-eclampsia/eclampsia, and what is monitored for toxicity?

    Magnesium sulfate ($\ce{MgSO4}$). Monitor respiratory rate, reflexes (loss of patellar reflex is early sign), and urine output; toxicity is reversed with calcium gluconate.

  7. What is the first-line oral antihypertensive for hypertension in pregnancy, and which common agents are contraindicated?

    First-line: labetalol (alternatives nifedipine, methyldopa). ACE inhibitors, ARBs and thiazide diuretics are contraindicated (teratogenic/fetotoxic).

  8. How and when is gestational diabetes screened for and diagnosed in the UK?

    75 g oral glucose tolerance test at 24–28 weeks in at-risk women (earlier if previous GDM). Diagnostic thresholds: fasting glucose $\geq 5.6\ \text{mmol/L}$ or 2-hour glucose $\geq 7.8\ \text{mmol/L}$.

  9. What is the first-line management of gestational diabetes when fasting glucose is below $7\ \text{mmol/L}$ at diagnosis?

    A 1–2 week trial of diet and exercise; if targets not met, add metformin, then insulin if needed. If fasting glucose is $\geq 7\ \text{mmol/L}$ at diagnosis, start insulin immediately.

  10. What defines placenta praevia and how does it classically present?

    Placenta lying wholly or partly in the lower uterine segment (over/near the internal os). Presents with painless bright-red vaginal bleeding; the uterus is soft and non-tender. Vaginal examination is avoided.

  11. What defines placental abruption and its classic clinical features?

    Premature separation of a normally sited placenta. Presents with painful vaginal bleeding (may be concealed), a tense/'woody' hard tender uterus, and signs of fetal distress; bleeding may be out of proportion to maternal shock.

  12. State the four criteria of the Bishop score and what a high score indicates.

    Cervical dilatation, effacement (length/consistency), station of presenting part, and cervical position/consistency. A higher score (typically $\geq 7$) predicts a favourable cervix likely to respond to induction.

  13. What are the three stages of labour?

    First stage: onset of regular contractions to full dilatation ($10\ cm$), divided into latent ($<4\ cm$) and active phases. Second stage: full dilatation to delivery of the baby. Third stage: delivery of the baby to delivery of the placenta and membranes.

  14. Define the cardinal movements (mechanism) of normal labour in order.

    Engagement and descent, flexion, internal rotation, extension (delivery of head), restitution/external rotation, then expulsion (delivery of shoulders and body).

  15. What is the immediate stepwise management sequence (mnemonic HELPERR) for shoulder dystocia?

    Call for Help, Evaluate for Episiotomy, Legs (McRoberts manoeuvre), suprapubic Pressure, Enter manoeuvres (internal rotation), Remove the posterior arm, Roll the patient onto all fours. McRoberts plus suprapubic pressure resolves most cases.

  16. Define primary postpartum haemorrhage and give the volume thresholds.

    Blood loss $\geq 500\ mL$ from the genital tract within 24 hours of delivery. Minor PPH: $500\text{–}1000\ mL$; major PPH: $>1000\ mL$. Secondary PPH occurs from 24 hours to 12 weeks postpartum.

  17. List the '4 Ts' causes of primary postpartum haemorrhage in order of frequency.

    Tone (uterine atony — most common, ~70%), Trauma (lacerations), Tissue (retained products), and Thrombin (coagulopathy).

  18. What is the first-line uterotonic for postpartum haemorrhage due to uterine atony, and what mechanical measures accompany it?

    IV/IM oxytocin (after bimanual uterine compression and rubbing up a contraction). Subsequent agents: ergometrine (avoid in hypertension), carboprost (avoid in asthma), and misoprostol.

  19. What is amniotic fluid embolism and its classic clinical triad?

    Amniotic fluid/fetal cells entering the maternal circulation, causing the triad of acute hypoxia (dyspnoea/cyanosis), cardiovascular collapse (hypotension), and coagulopathy (DIC), often around delivery. Management is supportive/resuscitative.

  20. What is uterine rupture, its key risk factor and presentation?

    Full-thickness disruption of the uterine wall. Main risk factor is a previous caesarean/uterine scar, especially during labour. Presents with sudden severe abdominal pain, cessation of contractions, fetal distress, vaginal bleeding and loss of station of the presenting part.

Show the other 41 Reproductive, Sexual and Women's Health flashcards
  1. What is the definition of recurrent miscarriage and one key investigation?

    Three or more consecutive pregnancy losses before 24 weeks. Investigations include antiphospholipid antibody screen (lupus anticoagulant, anticardiolipin), parental karyotyping and pelvic ultrasound for uterine anomalies.

  2. What is the typical hCG pattern, ultrasound finding and first-line management of an ectopic pregnancy?

    Serum hCG that fails to rise appropriately (suboptimal rise, often $<63\%$ in 48 h) with an empty uterus; an adnexal mass may be seen. Management options: expectant, medical (IM methotrexate) or surgical (salpingectomy/salpingotomy) depending on size, hCG and stability.

  3. Distinguish complete from partial hydatidiform mole by karyotype and origin.

    Complete mole: diploid ($46,XX$ usually), entirely paternal in origin (empty ovum fertilised), no fetal tissue. Partial mole: triploid (e.g. $69,XXY$), one maternal and two paternal sets, with some fetal tissue. Both need referral to a trophoblastic disease centre.

  4. What is the management of a threatened miscarriage with a viable intrauterine pregnancy and bleeding at 7 weeks?

    Expectant management. If the woman is $\geq 6$ weeks with bleeding, consider vaginal micronised progesterone if there is a history of previous miscarriage; repeat scan in 1 week to confirm viability. Anti-D is not required for threatened miscarriage before 12 weeks.

  5. Which women require anti-D prophylaxis after a sensitising event, and what test quantifies large feto-maternal haemorrhage?

    RhD-negative, non-sensitised women after sensitising events (delivery, bleeding, ECV, trauma, surgical management of miscarriage). Routine antenatal anti-D is given at 28 weeks. The Kleihauer test quantifies feto-maternal haemorrhage to guide additional anti-D dosing.

  6. What defines postpartum (puerperal) sepsis and the most common causative organisms?

    Infection of the genital tract from rupture of membranes/delivery up to 6 weeks postpartum. Common organisms: group A Streptococcus (Streptococcus pyogenes), E. coli, and Staphylococcus aureus. Group A Strep can cause rapid deterioration.

  7. What are the upper legal time limit and the two-doctor requirement for termination of pregnancy under the UK Abortion Act 1967?

    Most terminations are legal up to $24$ weeks (Ground C, risk to physical/mental health) with two registered doctors agreeing. There is no upper limit for grounds such as serious fetal abnormality (Ground E) or grave risk to the woman's life.

  8. Compare medical and surgical methods of termination of pregnancy.

    Medical: mifepristone (antiprogestogen) followed 24–48 h later by misoprostol (prostaglandin); used at any gestation. Surgical: vacuum aspiration (up to ~14 weeks) or dilatation and evacuation (later). All women are screened for chlamydia and offered contraception.

  9. How are maternal mortality figures categorised (direct vs indirect) and what is currently the leading cause of direct maternal death in the UK?

    Direct deaths result from obstetric complications (e.g. thrombosis, haemorrhage, pre-eclampsia, sepsis); indirect deaths from pre-existing/new disease aggravated by pregnancy (e.g. cardiac disease). Thrombosis and thromboembolism is the leading direct cause; cardiac disease is the leading overall cause.

  10. Define stillbirth, neonatal death and perinatal mortality rate.

    Stillbirth: fetal death at/after $24$ weeks gestation. Neonatal death: death of a liveborn baby within the first 28 days. Perinatal mortality rate = (stillbirths + early neonatal deaths) per 1000 total births.

  11. Define menorrhagia (heavy menstrual bleeding) and state the first-line medical treatment in a woman not wanting contraception.

    Heavy menstrual bleeding is excessive menstrual loss interfering with quality of life. First-line if no structural cause and contraception not desired: tranexamic acid (antifibrinolytic) and/or mefenamic acid (NSAID) during menses. The levonorgestrel IUS is first-line overall if contraception is acceptable.

  12. Define primary and secondary dysmenorrhoea and the first-line treatment of primary dysmenorrhoea.

    Primary: painful periods with no underlying pathology, typically starting with menarche. Secondary: due to underlying pathology (endometriosis, fibroids, adenomyosis, PID), often starting later. First-line for primary: NSAIDs (e.g. mefenamic acid); then combined oral contraceptive pill.

  13. What is the PALM-COEIN classification used for, and what do the two groups represent?

    FIGO classification of causes of abnormal uterine bleeding. PALM = structural causes (Polyp, Adenomyosis, Leiomyoma/fibroid, Malignancy/hyperplasia); COEIN = non-structural (Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified).

  14. Describe the typical clinical features distinguishing fibroids, adenomyosis and endometriosis.

    Fibroids (leiomyomas): firm enlarged non-tender 'bulky' uterus, menorrhagia, pressure symptoms. Adenomyosis: bulky, tender, 'boggy' uterus with menorrhagia and dysmenorrhoea in older parous women. Endometriosis: cyclical pelvic pain, dysmenorrhoea, deep dyspareunia, subfertility; 'chocolate cysts' (endometriomas).

  15. What is the gold-standard diagnostic investigation for endometriosis and the medical/surgical treatment options?

    Gold standard: laparoscopy (with biopsy). Treatment: analgesia/NSAIDs, hormonal suppression (COCP, progestogens, GnRH analogues), and surgical ablation/excision of deposits; severe disease may need hysterectomy with bilateral salpingo-oophorectomy.

  16. What are the diagnostic Rotterdam criteria for polycystic ovary syndrome?

    Two of three required: (1) oligo-/anovulation, (2) clinical or biochemical hyperandrogenism (hirsutism, raised testosterone), (3) polycystic ovaries on ultrasound ($\geq 12$ follicles or ovarian volume $>10\ mL$). Often associated with raised LH:FSH ratio and insulin resistance.

  17. What organisms cause pelvic inflammatory disease and what is the recommended outpatient antibiotic regimen?

    Commonly Chlamydia trachomatis and Neisseria gonorrhoeae (plus anaerobes/Mycoplasma genitalium). Typical outpatient regimen: IM ceftriaxone (single dose) plus oral doxycycline and metronidazole for 14 days.

  18. What is Fitz-Hugh-Curtis syndrome?

    Perihepatitis (inflammation of the liver capsule with 'violin-string' adhesions) caused by ascending pelvic infection, typically Chlamydia or gonorrhoea, presenting with right upper quadrant pain alongside PID.

  19. Classify urinary incontinence into its two main types and give first-line management of each.

    Stress incontinence (leakage on raised intra-abdominal pressure): first-line pelvic floor muscle training ($\geq 3$ months), then surgery (e.g. colposuspension/sling) or duloxetine. Urge incontinence/overactive bladder: bladder training ($\geq 6$ weeks), then antimuscarinics (e.g. oxybutynin) or mirabegron.

  20. How is pelvic organ prolapse graded using the POP-Q stage system in simple terms?

    Graded by how far the leading edge descends relative to the hymen: Stage 0 no prolapse; Stage 1 $>1\ cm$ above the hymen; Stage 2 within $1\ cm$ of the hymen; Stage 3 $>1\ cm$ beyond but not full descent; Stage 4 complete eversion/procidentia.

  21. Define the menopause and the hormonal changes that characterise it.

    Permanent cessation of menstruation, diagnosed retrospectively after $12$ months of amenorrhoea (mean age ~51). Hormonally: low oestrogen with high FSH and LH (loss of negative feedback). Premature menopause/POI is before age $40$.

  22. What is the key principle governing whether oestrogen-only or combined HRT is prescribed?

    Women with a uterus need combined oestrogen plus progestogen (the progestogen protects against endometrial hyperplasia/cancer). Women without a uterus can have oestrogen-only HRT. Add testosterone for low libido if needed.

  23. State the main risks associated with combined HRT.

    Increased risk of breast cancer (with combined HRT, related to duration), venous thromboembolism (lower with transdermal route), stroke (oral oestrogen), and—if started late—possible cardiovascular risk. Transdermal HRT avoids the first-pass VTE risk.

  24. Describe the UK cervical screening programme: ages, intervals and the primary test used.

    Women/people with a cervix aged 25–64 are screened. Primary test is high-risk HPV testing; if HPV-positive, cytology (reflex) is performed. Intervals: every 3 years for ages 25–49 and every 5 years for ages 50–64 (now moving to 5-yearly if HPV-negative).

  25. What is cervical intraepithelial neoplasia (CIN) and how do CIN grades relate to management?

    CIN is dysplasia of the cervical squamous epithelium graded by depth: CIN1 (lower third, often regresses—monitored), CIN2 (two-thirds), CIN3 (full thickness, carcinoma in situ). CIN2/3 is treated, usually by large loop excision of the transformation zone (LLETZ).

  26. Which HPV subtypes cause most cervical cancer and which are covered by the UK vaccine?

    High-risk types 16 and 18 cause ~70% of cervical cancers. The Gardasil 9 vaccine covers 16, 18, 31, 33, 45, 52, 58 (oncogenic) plus 6 and 11 (genital warts), offered to all children around age 12–13.

  27. What is the classic presentation and main risk factors for endometrial cancer?

    Postmenopausal bleeding is the cardinal symptom. Risk factors reflect unopposed oestrogen excess: obesity, nulliparity, early menarche/late menopause, PCOS, tamoxifen, oestrogen-only HRT, Lynch syndrome. Investigated with transvaginal ultrasound (endometrial thickness $>4\ mm$) and hysteroscopy + biopsy.

  28. What tumour marker and risk-stratification tool are used for a suspected ovarian malignancy, and the commonest histological type?

    CA-125 is the tumour marker; the Risk of Malignancy Index ($RMI = U \times M \times CA\text{-}125$) combines ultrasound score, menopausal status and CA-125. The commonest ovarian cancers are epithelial (serous) carcinomas. BRCA1/2 mutations markedly raise risk.

  29. What is lichen sclerosus, its typical appearance and its key long-term risk?

    A chronic inflammatory vulval dermatosis causing itchy, white, atrophic 'parchment-like' or figure-of-eight perianal skin changes. Treated with potent topical steroids (e.g. clobetasol). It carries a small increased risk of vulval squamous cell carcinoma, so requires monitoring.

  30. Rank common reversible contraceptives by typical-use effectiveness and name the most effective category.

    LARCs (long-acting reversible contraceptives) — the implant, IUS and copper IUD — are most effective ($>99\%$, user-independent). The implant is the single most effective. Oral pills, patch and ring are effective but more failure-prone with typical use; barrier methods least effective.

  31. What are the key UKMEC contraindications to the combined oral contraceptive pill (UKMEC 4)?

    Absolute contraindications include migraine with aura, history of VTE/known thrombophilia, BP $\geq 160/100$, smoking $\geq 15$/day at age $\geq 35$, current breast cancer, $<6$ weeks postpartum and breastfeeding, and major surgery with immobilisation. These reflect the prothrombotic/oestrogenic risks.

  32. Compare the emergency contraception options and their time windows.

    Copper IUD: most effective, insert up to 5 days after unprotected sex or 5 days after expected ovulation. Ulipristal acetate (ellaOne): oral, up to 120 h (5 days). Levonorgestrel: oral, up to 72 h (3 days, higher dose if BMI $>26$). The copper IUD is the only one that prevents implantation directly.

  33. Compare the discharge characteristics of bacterial vaginosis, candidiasis and trichomoniasis.

    Bacterial vaginosis: thin grey-white fishy-smelling discharge, pH $>4.5$, clue cells, no soreness (treat metronidazole). Candidiasis: thick white 'cottage cheese' discharge with itch, normal pH (treat clotrimazole/fluconazole). Trichomoniasis: frothy yellow-green offensive discharge, 'strawberry cervix', pH $>4.5$ (treat metronidazole).

  34. Describe the presentation and treatment of genital chlamydia and gonorrhoea.

    Chlamydia trachomatis: often asymptomatic; commonest UK STI; treat with doxycycline 7 days. Neisseria gonorrhoeae: purulent urethral/cervical discharge; treat with IM ceftriaxone single dose. Both require partner notification and a test of cure for gonorrhoea.

  35. Outline the stages of untreated syphilis and the causative organism.

    Caused by Treponema pallidum. Primary: painless chancre. Secondary: widespread maculopapular rash (incl. palms/soles), condylomata lata. Latent: asymptomatic, positive serology. Tertiary: gummata, cardiovascular and neurosyphilis. Treated with IM benzylpenicillin.

  36. Define subfertility and the standard first-line investigations of the couple.

    Failure to conceive after $12$ months of regular unprotected intercourse (or 6 months if woman $>35$). Investigations: semen analysis (male); mid-luteal (day 21) progesterone to confirm ovulation, and tubal patency (HSG or laparoscopy) plus chlamydia screening (female).

  37. A day-21 progesterone confirms ovulation at what threshold, and what does this assume about cycle length?

    A mid-luteal serum progesterone $>30\ \text{nmol/L}$ confirms ovulation. 'Day 21' assumes a 28-day cycle; it should be taken 7 days before the expected next period, so adjust timing for longer/shorter cycles.

  38. What is the structure of a sexual health/STI risk assessment consultation?

    Take a focused sexual history: nature/date of last sexual contact, partner's gender and risk, sites of exposure, condom use, symptoms, previous STIs and testing, contraception, and assess risk for HIV/blood-borne viruses. Offer appropriate triple-site testing, partner notification, safeguarding screening and health promotion.

  39. What is HELLP syndrome and its three laboratory components?

    A severe variant of pre-eclampsia: Haemolysis, Elevated Liver enzymes, and Low Platelets. Presents with right upper quadrant/epigastric pain, nausea and malaise; definitive management is delivery.

  40. What is the definition of prolonged pregnancy and the rationale for offering induction?

    Pregnancy continuing beyond $42^{+0}$ weeks (post-term). Induction of labour is typically offered between 41 and 42 weeks to reduce the increased risks of stillbirth, meconium aspiration and placental insufficiency associated with prolongation.

  41. Describe obstetric cholestasis: presentation, key investigation and main fetal risk.

    Pruritus (especially palms and soles) without rash in the second/third trimester, with raised serum bile acids and transaminases. Main fetal risk is stillbirth, so delivery is often planned around 37–38 weeks; ursodeoxycholic acid may relieve itch.

UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health FAQ

What is in the UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health syllabus?

UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health is split into 5 chapters: Obstetrics: Antenatal and Intrapartum Care, Obstetrics: Early Pregnancy and Postnatal Care, Gynaecology, Gynaecological Oncology and Contraception, Sexual and Reproductive Health. Together they contain 22 topics and 44 sub-topics.

How many chapters are in UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health?

5 chapters, containing 22 topics and 44 sub-topics. The largest chapter is Obstetrics: Antenatal and Intrapartum Care, with 5 topics.

Are there flashcards for UK Medical Licensing Assessment (UKMLA) Reproductive, Sexual and Women's Health?

Yes — a 61-card Reproductive, Sexual and Women's Health deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.